<SEC-DOCUMENT>0000105770-16-000104.txt : 20161214
<SEC-HEADER>0000105770-16-000104.hdr.sgml : 20161214
<ACCEPTANCE-DATETIME>20161214113033
ACCESSION NUMBER:		0000105770-16-000104
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20161214
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161214
DATE AS OF CHANGE:		20161214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		162050566

	BUSINESS ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dec142016form8k.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5FE7AF3C93CB8F38EE35FD396BEAC55A"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:4px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (Date of Earliest Event Reported) &#8211; December 14, 2016 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><img src="wst8klogodec142016.jpg" alt="wst8klogodec142016.jpg" style="height:101px;width:252px;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:33%;"></td><td style="width:4%;"></td><td style="width:27%;"></td><td style="width:4%;"></td><td style="width:32%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pennsylvania</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-8036</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23-1210010</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of Incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530 Herman O. West Drive, Exton, PA</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19341-0645</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Registrant&#8217;s telephone number, including area code: </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">610-594-2900</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not Applicable</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former name or address, if changed since last report)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s0B02F60F14A1F9381F77FD396C198323"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01 Regulation FD Disclosure.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 14, 2016, West Pharmaceutical Services, Inc. (the "Company") announced that its Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 to shareholders of record as of January 18, 2017. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in Item 7.01 of this report and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purpose of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A copy of the press release issued by the Company is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01 Other Events.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Also on December 14, 2016, the Company announced a share repurchase program authorizing the repurchase of up to 800,000 shares of the Company's common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions, but the program will commence on January 1, 2017 and is expected to be completed by December 31, 2017. The Company's previously-authorized share repurchase program expires on December 31, 2016.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01&#160;Financial Statements and Exhibits.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:9%;"></td><td style="width:12%;"></td><td style="width:79%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibits</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated December 14, 2016.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><a name="sADB3D7A195F2281332C3FD396C48163C"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:44%;"></td><td style="width:41%;"></td><td style="width:15%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ William J. Federici</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Federici</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 14, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><a name="s46BA926D2249143A7CBEFD396C67AF75"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated December 14, 2016.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh991dec142016pressrelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3F7081E7AEC1D5513441FD396B4EBA45"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><img src="exh991logodec142016.jpg" alt="exh991logodec142016.jpg" style="height:57px;width:337px;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:right;padding-left:54px;text-indent:0px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:395px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:394px;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Investor and Media Contact:</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">West</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Quintin Lai, Investor Relations</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">+1-610-594-3318</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Quintin.Lai@westpharma.com</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">West Announces Quarterly Dividend and Share Repurchase Program</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EXTON, PA, December 14, 2016 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company&#8217;s Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 to shareholders of record as of January 18, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company also announced a share repurchase program authorizing the repurchase of up to 800,000 shares of the Company's common stock from time to time on the open market or in privately-negotiated transactions as permitted under Securities Exchange Act of 1934 Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions, but the program will commence on January 1, 2017 and is expected to be completed by December 31, 2017. The Company's previously-authorized share repurchase program expires on December 31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About West</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">West Pharmaceutical Services, Inc., is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2015 sales of $1.4 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exh991logodec142016.jpg
<TEXT>
begin 644 exh991logodec142016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M+;;-&)$ <R+D[2,C'%>9:C_P<N_L]Z=8S3G2/BE*(D+[(_#REWP/N@>=R3T
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MM^#,OB$Z#K7B_P 0WS-:Z%X?TFTFN+K5;K;NP?*1S'"H^9Y2N%& ,LRJ=?\
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MX?U+XZ>)6T[P5I^I^-]9N),O#HD+ZI.SGO(8MV"<=7(Z5^L?_!(K_@AYX@\
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M:5]KWZ>1V'QU\!W^O^-)=0\6>-(_#/@F",K:Q6MV8IW<*.JE<,Q)8DX8@
M9R.4^"?C2^UOX._$K2I]3N-7L-*LW:QGG9F=HV64 Y8D@,$5MI/&XBHO$&H?
MV3^U-K%YXL\-:UXD5,QZ);P6IGCQN7RBH)"E=N[G) 8DD=POP<TG4E\._&!K
MO2KVQN+VW=UMWA;ABUP2B':-^TG&5Z\>M8*%J%I._P +6UMUMU]6=[J<^.<Z
M::NZB=^9MVB[7Z)?RI'':_IMR_[*FAWRWC+8V^LW,$MEM^6>1@624MG@J$9<
M8YWGFMWXN>%]7\/6'PV@N]=DU.[NY/.M;F6#_CS5VMO+3:6.X)UZC..U/O\
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,J* $1-@I:** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>wst8klogodec142016.jpg
<TEXT>
begin 644 wst8klogodec142016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !5 -(# 2(  A$! Q$!_\0
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MZYQ?3OM2@I/Y-V_%HZ,%C/J?"%2VCJS<5\[7_!,^'"<"OZ#_ /@W_P#V7O\
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M/^NIK@?@=\)M3_:'^-WA7P78/)-JGC#5[?31*3E@9I 'E)_V5+.3Z U]A_\
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MV-'\.+6[<>&_AI;1JT"-\DVHW$:RRRL.Y2-XXQGI\^/O&O$O^",_PQ?XJ_\
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M$OO@WX>\8>++?X:R_"FTUS6-8T[4-/-_*K37#RH"8Y@JA(5)P"W^L/TKNO\
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M(U7X-:W'X=\)2_VL8T-NEEIL]A>%A(APES)&Z1\9R6SD9'4UXC^SG^TMX/\
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M/]F_U-JI]O+C\P?]=C7X]_\ !5GQ%_PE'_!2+XT76[>$\3SVH/M"J0_^TZ^
MR;&_7>*<353O&G#D7RDK_C<_0,ZP7U'A;#TGI*I/G?S3M^%CQ%O%UZ?!:Z )
M"--6_.I&,?QS&)8@Q^B@@?[QKZ'_ ."07[+H_:P_;Z\$:)=6WVG0M"G/B+6
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
